Importantly, cancer-associated BAP1 mutations are defective in SLC7A11 regulation and ferroptosis, suggesting that SLC7A11-mediated ferroptosis has a role in the tumor-suppressive function of BAP1. This evidence concerns the gene SLC7A11 and neoplasm.